These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28101792)

  • 1. Medical Management of Diabesity: Do We Have Realistic Targets?
    Pappachan JM; Viswanath AK
    Curr Diab Rep; 2017 Jan; 17(1):4. PubMed ID: 28101792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with GLP-1 analogues and SGLT-2 inhibitors in the management of diabesity: the real world experience.
    Deol H; Lekkakou L; Viswanath AK; Pappachan JM
    Endocrine; 2017 Jan; 55(1):173-178. PubMed ID: 27696231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabesity and antidiabetic drugs.
    Pappachan JM; Fernandez CJ; Chacko EC
    Mol Aspects Med; 2019 Apr; 66():3-12. PubMed ID: 30391234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of 'Diabesity': Beyond Pharmacotherapy.
    Singh H; Venkatesan V
    Curr Drug Targets; 2018; 19(14):1672-1682. PubMed ID: 29929463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [GLP-1 receptor agonists versus SGLT-2 inhibitors in obese type 2 diabetes patients].
    Marques AR; Jaafar J; de Kalbermatten B; Philippe J
    Rev Med Suisse; 2015 Jun; 11(477):1227-8, 1230-3. PubMed ID: 26211282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on cardiovascular effects of newer hypoglycaemic medications.
    Cutshall BT; Twilla JD; Olinger AS; Oliphant CS
    Ann Med; 2017 Nov; 49(7):603-612. PubMed ID: 28540743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLP-1 receptor agonists for type 2 diabetes mellitus: recent developments and emerging agents.
    Trujillo JM; Nuffer W
    Pharmacotherapy; 2014 Nov; 34(11):1174-86. PubMed ID: 25382096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing highly insulin-resistant diabetes mellitus: weight loss approaches and medical management.
    Brown A; Desai M; Taneja D; Tannock LR
    Postgrad Med; 2010 Jan; 122(1):163-71. PubMed ID: 20107300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity.
    Lorenz M; Evers A; Wagner M
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4011-8. PubMed ID: 23743288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of weight in the management of patients with type 2 diabetes mellitus: towards an adipocentric approach to diabetes.
    Gorgojo Martínez JJ
    Med Clin (Barc); 2016 Nov; 147 Suppl 1():8-16. PubMed ID: 28760227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.
    Iepsen EW; Torekov SS; Holst JJ
    Expert Opin Pharmacother; 2014 Dec; 15(17):2487-500. PubMed ID: 25260877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in diabetes management: medications of the 21st century.
    Fonseca VA
    Clin Ther; 2014 Apr; 36(4):477-84. PubMed ID: 24594068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.
    Yandrapalli S; Jolly G; Horblitt A; Sanaani A; Aronow WS
    Postgrad Med; 2017 Nov; 129(8):811-821. PubMed ID: 28749197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative Agents in Type 1 Diabetes in Addition to Insulin Therapy: Metformin, Alpha-Glucosidase Inhibitors, Pioglitazone, GLP-1 Agonists, DPP-IV Inhibitors, and SGLT-2 Inhibitors.
    DeGeeter M; Williamson B
    J Pharm Pract; 2016 Apr; 29(2):144-59. PubMed ID: 25312263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabesity.
    Kalra S
    J Pak Med Assoc; 2013 Apr; 63(4):532-4. PubMed ID: 23905459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of diabesity: Current concepts.
    Michaelidou M; Pappachan JM; Jeeyavudeen MS
    World J Diabetes; 2023 Apr; 14(4):396-411. PubMed ID: 37122433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and glucagon-like peptide receptor agonist (GLP 1 RA) combinations.
    Kalra S
    J Pak Med Assoc; 2014 Mar; 64(3):359-61. PubMed ID: 24864619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug treatments to restore vascular function and diabesity.
    Cardillo C
    Ann Pharm Fr; 2013 Jan; 71(1):27-33. PubMed ID: 23348853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating Diabetes in Patients with Heart Failure: Moving from Risk to Benefit.
    DeFilippis EM; Givertz MM
    Curr Heart Fail Rep; 2016 Jun; 13(3):111-8. PubMed ID: 27188181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.